Recro Pharma REPH
$ 1.4
-4.76%
Annual report 2023
added 03-22-2024
Country |
USA |
IPO year |
2014 |
Industry |
Drug manufacturers |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Ms. Geraldine Henwood |
Employees in the company |
213 |
Shares |
95.2 M |
Market Cap[1] |
$ 65.3 M |
EBITDA (LTM) |
$ -2.62 M |
P/E (LTM) |
-6.67 |
P/S (LTM) |
0.74 |
EPS (LTM) |
-0.21 |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.